Literature DB >> 23526328

Interventional treatment of hypertension: a new paradigm.

W Schuyler Jones1, Sreekanth Vemulapalli, Manesh R Patel.   

Abstract

Hypertension is thought to contribute to more than 7 million deaths worldwide each year and contributes to the development of atherosclerotic lesions that lead to myocardial infarction and stroke. While lifestyle modifications (diet, exercise, weight loss) and pharmacotherapy have been proven to be effective in the treatment of hypertension, as many as half of patients have uncontrolled BP and remain at risk for elevated cardiovascular morbidity and mortality. The main physiologic targets for interventional treatment include alteration of blood flow to the kidney, activation of the carotid baroreflex system, and modification of the renal sympathetic nervous system. The results of prior studies and new studies of interventional treatments of resistant hypertension are covered in this review.

Entities:  

Mesh:

Year:  2013        PMID: 23526328     DOI: 10.1007/s11886-013-0356-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  40 in total

1.  Hypertension and associated cardiovascular disease; comparison of male and female mortality rates and their influence on selection of therapy.

Authors:  R H SMITHWICK; R D BUSH; D KINSEY; G P WHITELAW
Journal:  J Am Med Assoc       Date:  1956-03-24

2.  Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.

Authors:  Dirk Prochnau; Norma Lucas; Helmut Kuehnert; Hans R Figulla; Ralf Surber
Journal:  EuroIntervention       Date:  2012-01       Impact factor: 6.534

3.  Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

Authors:  Clive Rosendorff; Henry R Black; Christopher P Cannon; Bernard J Gersh; Joel Gore; Joseph L Izzo; Norman M Kaplan; Christopher M O'Connor; Patrick T O'Gara; Suzanne Oparil
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

4.  First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension.

Authors:  Tom Mabin; Marc Sapoval; Vincent Cabane; Joanne Stemmett; Mano Iyer
Journal:  EuroIntervention       Date:  2012-05-15       Impact factor: 6.534

5.  Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.

Authors:  Mathias C Brandt; Sara Reda; Felix Mahfoud; Matthias Lenski; Michael Böhm; Uta C Hoppe
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.

Authors:  Kerstin Wustmann; Jan P Kucera; Ingrid Scheffers; Markus Mohaupt; Abraham A Kroon; Peter W de Leeuw; Jürg Schmidli; Yves Allemann; Etienne Delacrétaz
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

8.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-03-21       Impact factor: 24.094

Review 9.  Management of renal artery stenosis: the case for intervention, defending current guidelines, and screening (drive-by) renal angiography at the time of catheterization.

Authors:  Christopher J White
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

View more
  3 in total

Review 1.  Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Authors:  Christian Schenk; Timothy Wuerz; Alan J Lerner
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 2.  To Stent or Not to Stent? Update on Revascularization for Atherosclerotic Renovascular Disease.

Authors:  Elias Noory; Kaji Sritharan; Thomas Zeller
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

3.  Effect of green tea supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Renfan Xu; Ke Yang; Jie Ding; Guangzhi Chen
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.